These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 23746054)

  • 21. Characterization of immune responses during infection with Mycobacterium avium strains 100, 101 and the recently sequenced 104.
    Saunders BM; Dane A; Briscoe H; Britton WJ
    Immunol Cell Biol; 2002 Dec; 80(6):544-9. PubMed ID: 12406388
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Production of TNF-alpha, IL-6 and TGF-beta, and expression of receptors for TNF-alpha and IL-6, during murine Mycobacterium avium infection.
    Champsi J; Young LS; Bermudez LE
    Immunology; 1995 Apr; 84(4):549-54. PubMed ID: 7790028
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of gamma interferon and tumor necrosis factor alpha during T-cell-independent and -dependent phases of Mycobacterium avium infection.
    Appelberg R; Castro AG; Pedrosa J; Silva RA; Orme IM; Minóprio P
    Infect Immun; 1994 Sep; 62(9):3962-71. PubMed ID: 8063414
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mice lacking myeloid differentiation factor 88 display profound defects in host resistance and immune responses to Mycobacterium avium infection not exhibited by Toll-like receptor 2 (TLR2)- and TLR4-deficient animals.
    Feng CG; Scanga CA; Collazo-Custodio CM; Cheever AW; Hieny S; Caspar P; Sher A
    J Immunol; 2003 Nov; 171(9):4758-64. PubMed ID: 14568952
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neutrophils from Mycobacterium avium-infected mice produce TNF-alpha, IL-12, and IL-1 beta and have a putative role in early host response.
    Petrofsky M; Bermudez LE
    Clin Immunol; 1999 Jun; 91(3):354-8. PubMed ID: 10370382
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunological basis of the development of necrotic lesions following Mycobacterium avium infection.
    Flórido M; Cooper AM; Appelberg R
    Immunology; 2002 Aug; 106(4):590-601. PubMed ID: 12153523
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CD40 is required for the optimal induction of protective immunity to Mycobacterium avium.
    Flórido M; Gonçalves AS; Gomes MS; Appelberg R
    Immunology; 2004 Mar; 111(3):323-7. PubMed ID: 15009433
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Infection of mice with Mycobacterium avium primes CD8+ lymphocytes for apoptosis upon exposure to macrophages.
    Roger PM; Bermudez LE
    Clin Immunol; 2001 Jun; 99(3):378-86. PubMed ID: 11358435
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic control of immune-mediated necrosis of Mycobacterium avium granulomas.
    Flórido M; Appelberg R
    Immunology; 2006 May; 118(1):122-30. PubMed ID: 16630029
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cross-reactive immune responses against Mycobacterium bovis BCG in mice infected with non-tuberculous mycobacteria belonging to the MAIS-Group.
    Lozes E; Denis O; Drowart A; Jurion F; Palfliet K; Vanonckelen A; De Bruyn J; De Cock M; Van Vooren JP; Huygen K
    Scand J Immunol; 1997 Jul; 46(1):16-26. PubMed ID: 9246204
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differences in resistance of C57BL/6 and C57BL/10 mice to infection by Mycobacterium avium are independent of gamma interferon.
    Appelberg R; Leal IS; Pais TF; Pedrosa J; Flórido M
    Infect Immun; 2000 Jan; 68(1):19-23. PubMed ID: 10603363
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Resistance of virulent Mycobacterium avium to gamma interferon-mediated antimicrobial activity suggests additional signals for induction of mycobacteriostasis.
    Flórido M; Gonçalves AS; Silva RA; Ehlers S; Cooper AM; Appelberg R
    Infect Immun; 1999 Jul; 67(7):3610-8. PubMed ID: 10377146
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interleukin-12p40 mediates transient protection against Mycobacterium avium infection in the absence of interleukin-12.
    Ehlers S; Lehmann J; Mossmann H; Alber G; Hölscher C
    Immunobiology; 2005; 210(2-4):217-27. PubMed ID: 16164029
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The relative impact of bacterial virulence and host genetic background on cytokine expression during Mycobacterium avium infection of mice.
    Castro AG; Minóprio P; Appelberg R
    Immunology; 1995 Aug; 85(4):556-61. PubMed ID: 7558149
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mice deficient in LRG-47 display increased susceptibility to mycobacterial infection associated with the induction of lymphopenia.
    Feng CG; Collazo-Custodio CM; Eckhaus M; Hieny S; Belkaid Y; Elkins K; Jankovic D; Taylor GA; Sher A
    J Immunol; 2004 Jan; 172(2):1163-8. PubMed ID: 14707092
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protective role of interferon gamma, tumor necrosis factor alpha and interleukin-6 in Mycobacterium tuberculosis and M. avium infections.
    Appelberg R
    Immunobiology; 1994 Oct; 191(4-5):520-5. PubMed ID: 7713566
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Control of Mycobacterium fortuitum and Mycobacterium intracellulare infections with respect to distinct granuloma formations in livers of BALB/c mice.
    Silva TR; Petersen AL; Santos Tde A; Almeida TF; Freitas LA; Veras PS
    Mem Inst Oswaldo Cruz; 2010 Aug; 105(5):642-8. PubMed ID: 20835610
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Toll-like receptor 6 senses Mycobacterium avium and is required for efficient control of mycobacterial infection.
    Marinho FA; de Paula RR; Mendes AC; de Almeida LA; Gomes MT; Carvalho NB; Oliveira FS; Caliari MV; Oliveira SC
    Eur J Immunol; 2013 Sep; 43(9):2373-85. PubMed ID: 23716075
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The combination of plasmid interleukin-12 with a single DNA vaccine is more effective than Mycobacterium bovis (bacille Calmette-Guèrin) in protecting against systemic Mycobacterim avium infection.
    Martin E; Kamath AT; Briscoe H; Britton WJ
    Immunology; 2003 Jun; 109(2):308-14. PubMed ID: 12757627
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.